Nepotism, Toxicity, and Little to Show for It
Pros
The interviews and the promises made at the time of recruitment gives the impression of a promising and innovative research environment.
Cons
The company’s perspective on science appears limited, likely a reflection of operating in a small, insular environment with limited exposure to broader scientific communities and standards. Leadership culture is challenging — there is little room for independent thinking, and a tendency toward favoritism and nepotism is evident at the highest levels of management. The Chief Scientific Officer in particular sets a troubling tone for the toxic work culture. Her management style includes publicly demeaning and belittling employees she doesn’t like or feels threatened by. This behavior from someone in such a senior role is deeply damaging to employee morale and goes unchecked. Despite considerable time in operation, the company has little in terms of tangible products or outcomes to demonstrate. Compensation is below market for the level of expertise they recruit. The gap between what is promised during hiring and the day-to-day reality can be disappointing. Employees do not feel genuinely valued, and there is minimal investment in professional development or long-term career growth. Companies in the biotech space that make ambitious claims without accountability would benefit from greater external oversight and transparency. Prospective candidates are encouraged to ask hard questions during the interview process and look beyond the initial enthusiasm before committing.